LSD microdosing and the menstrual cycle

This study measures the brain's response to drug changes during the menstrual cycle, particularly the effect of serotonergic-acting drugs. Participants will track their menstrual cycle and receive low dose LSD (the study drug) that modifies serotonergic signalling during different phases of the cycle. Their EEG and blood samples will be measured. 

You can find the study pre-screening questionnaire here.

To participate in this study, you must

• Be aged 18-46 years
• Have a regular menstrual cycle
• Not be taking any hormonal contraception
• Be willing to take the study drug
• Be willing to participate for five months
• Have mild to no PMS symptoms

Farheen Kothiwala
PhD candidate
Email: pmdd@auckland.ac.nz
Phone: 027 204 6170 (MDMENS team)